fbpx
01 / 05
1,000 Bits of Good News You May Have Missed in 2023

Blog Post | Human Development

1,000 Bits of Good News You May Have Missed in 2023

A necessary balance to the torrent of negativity.

Reading the news can leave you depressed and misinformed. It’s partisan, shallow, and, above all, hopelessly negative. As Steven Pinker from Harvard University quipped, “The news is a nonrandom sample of the worst events happening on the planet on a given day.”

So, why does Human Progress feature so many news items? And why did I compile them in this giant list? Here are a few reasons:

  • Negative headlines get more clicks. Promoting positive stories provides a necessary balance to the torrent of negativity.
  • Statistics are vital to a proper understanding of the world, but many find anecdotes more compelling.
  • Many people acknowledge humanity’s progress compared to the past but remain unreasonably pessimistic about the present—not to mention the future. Positive news can help improve their state of mind.
  • We have agency to make the world better. It is appropriate to recognize and be grateful for those who do.

Below is a nonrandom sample (n = ~1000) of positive news we collected this year, separated by topic area. Please scroll, skim, and click. Or—to be even more enlightened—read this blog post and then look through our collection of long-term trends and datasets.

Agriculture

Aquaculture

Farming robots and drones

Food abundance

Genetic modification

Indoor farming

Lab-grown produce

Pollination

Other innovations

Conservation and Biodiversity

Big cats

Birds

Turtles

Whales

Other comebacks

Forests

Reefs

Rivers and lakes

Surveillance and discovery

Rewilding and conservation

De-extinction

Culture and tolerance

Gender equality

General wellbeing

LGBT

Treatment of animals

Energy and natural Resources

Fission

Fusion

Fossil fuels

Other energy

Recycling and resource efficiency

Resource abundance

Environment and pollution

Climate change

Disaster resilience

Air pollution

Water pollution

Growth and development

Education

Economic growth

Housing and urbanization

Labor and employment

Health

Cancer

Disability and assistive technology

Dementia and Alzheimer’s

Diabetes

Heart disease and stroke

Other non-communicable diseases

HIV/AIDS

Malaria

Other communicable diseases

Maternal care

Fertility and birth control

Mental health and addiction

Weight and nutrition

Longevity and mortality 

Surgery and emergency medicine

Measurement and imaging

Health systems

Other innovations

Freedom

    Technology 

    Artificial intelligence

    Communications

    Computing

    Construction and manufacturing

    Drones

    Robotics and automation

    Autonomous vehicles

    Transportation

    Other innovations

    Science

    AI in science

    Biology

    Chemistry and materials

      Physics

      Space

      Violence

      Crime

      War

      New York Times | Vaccination

      Vaccines Are Helping Older People More than We Knew

      “In 21 studies involving more than 104 million participants in Europe, Asia and North America, vaccination against shingles was associated with a 24 percent reduction in the risk of developing dementia. Flu vaccination was linked to a 13 percent reduction. Those vaccinated for pneumococcal infection had a 36 percent reduction in Alzheimer’s risk.

      The Tdap vaccine against tetanus, diphtheria and pertussis (whooping cough) is recommended for adults every 10 years, with vaccination among older adults often prompted by the birth of a grandchild, who cannot be fully vaccinated for months. It was associated with a one-third decline in dementia.

      Other researchers are investigating the effects of shingles vaccination on heart attacks and stroke and of Covid vaccination on cancer survival.

      What causes such vaccine bonuses? Most hypotheses focus on the inflammation that arises when the immune system mobilizes to fight off an infection.”

      From New York Times.

      Telegraph | Vaccination

      Major Milestone in Development of Nipah Virus Vaccine

      “An Oxford-designed vaccine for Nipah virus has launched phase two trials, in a ‘major milestone’ for efforts to curb the deadly pathogen and boost pandemic preparedness.

      The disease – which inspired the Hollywood blockbuster Contagion – is rare but extremely deadly, with a fatality rate as high as 75 per cent. The World Health Organization considers it a priority pathogen for research, as no vaccines or treatments currently exist to tackle it.

      This month a jab developed by the University of Oxford, which uses the same ChAdOx platform as the institution’s Covid-19 shot, became the first Nipah vaccine candidate to enter phase two clinical trials to assess safety and the immune response.

      It is also the first vaccine to be trialled in a region directly affected by the virus. Bangladesh has sporadic outbreaks every year, with Nipah mostly spreading from fruit bats to people via contaminated raw date palm sap – although some human-to-human transmission through bodily fluids is also possible.”

      From Telegraph.

      Taiwan News | Vaccination

      Taiwan Achieves Hepatitis C Targets Ahead of Schedule

      “Taiwan has achieved its hepatitis C elimination targets ahead of schedule and plans to apply for World Health Organization certification by year’s end…

      Taiwan was the first country to introduce universal hepatitis B vaccination for newborns in 1986, sharply reducing hepatitis B prevalence and liver cancer rates among younger generations. The hepatitis C virus was identified by the international medical community in 1989.

      Taiwan launched a second major campaign against hepatitis with HCV treatment programs in 2003 and accelerated progress under a national policy framework in 2016. The government set a target of eliminating hepatitis C by the end of this year.

      Health Promotion Administration Director-General Shen Ching-fen (沈靜芬) said Taiwan exceeded gold-standard benchmarks, with a diagnosis rate of 90.2% and a treatment rate of 90.6%.”

      From Taiwan News.

      Doctors Without Borders | Vaccination

      Ethiopia’s R21 Malaria Vaccine Rollout, a Global First in a Refugee Camp

      “Médecins Sans Frontières (MSF) has completed the first full round of R21 malaria vaccine in Ethiopia, and the first ever completed in a refugee camp globally. In Kule refugee camp, in Gambella region, home to more than 55,000 South Sudanese refugees, 2,100 children under five received their fourth and final dose in November 2025.

      ‘This is the first time the R21 vaccine has been fully implemented in Ethiopia, and one of the earliest comprehensive rollouts on the African continent. It is also the first full vaccination round carried out in a refugee camp anywhere in the world.’ …

      In 2024, malaria transmission in the camp reached the highest level in five years. In response, MSF introduced the R21 vaccine in August as part of an expanded prevention package…

      In the period after the first vaccination campaign and other preventive measures, Kule hospital saw close to 50 percent fewer malaria-related deaths in 2025 compared to 2024. Where multiple factors could have had an impact on this significant decrease, it is highly likely the efforts carried out by the medical teams in the camp played a key role in this reduction.”

      From Doctors Without Borders.